Articles from Medimaps Group S.A.

Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, and Radiobotics ApS, a leader in AI-powered MSK radiology solutions, today announced that they have entered into a strategic merger agreement. Closing of the transaction is subject to receipt of Danish foreign direct investment (FDI) approval and other customary closing conditions. The merger will combine the two specialized AI medical imaging analysis companies to accelerate the adoption of AI-enabled musculoskeletal imaging, bringing complementary technologies, clinical validation, and global commercial capabilities together under a unified MSK vision.

Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, today announced the first live presentations of its new software TBS Reveal* at the prestigious Radiological Society of North America (RSNA) 2025 Annual Meeting, taking place in Chicago, IL, from November 30 to December 4.

Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, is further expanding its presence in the U.S. with the launch of its FDA-cleared next-generation TBS Osteo Advanced software. This milestone reflects the company's commitment to advancing osteoporosis detection and bone health management in the U.S. market with innovative solutions.

medimaps group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, proudly announces 510(k) clearance from FDA and MDR certification in EU for the latest version of its flagship Trabecular Bone Score (TBS) software, TBS Osteo. This next generation software is designed to enhance bone microarchitecture evaluation, broaden patient eligibility, and improve connectivity within medical facilities. The company is planning to rollout the next generation of TBS Osteo in its current 90 markets worldwide.